US DOHaD Abstract Submission Process
There will be two types of presentations at the conference: oral and poster, and the top three presenters for each presentation format will be recognized and awarded. At submission, authors can choose a theme that best aligns with their abstract from the following:
- Topic 1: Exposome: Big data, big impacts
- Topic 2: Non-chemical stressors and child health
- Topic 3: Multi-generational health effects
- Topic 4: Multi-level approach on metabolic diseases
- Topic 5: Innovations and novel approaches
Presenters can indicate if they are willing to give an oral presentation, but it does not guarantee selection. Leadership and organizing committees will review all abstracts for scientific merit and content. Outstanding abstracts fitting the themes will be selected for oral presentation. All presentations will be in-person, with posters presented during evening poster sessions on July 9th, and specific oral platform presentation times outlined in the final program. Full abstracts will be published on the website.
All abstracts must be submitted online prior to the deadline: 11:59 PM (EST) on April 16th, 2026, to be considered for an oral presentation.
NOTIFICATION OF ABSTRACT ACCEPTANCE
Authors of abstracts submitted for oral presentation will be notified by e-mail of the US DOHaD Program Committee's decision regarding acceptance of the abstract approximately 3 weeks after the abstract submission deadline. Abstracts submitted for poster presentations will be reviewed on a rolling basis up until the 11:59 PM (EST) May 17th, 2026 deadline and will not be eligible for consideration for oral platform presentation format.
ABSTRACT SUBMISSION GUIDLINES can be found on the Annual Meeting page.